Applied Immune Technologies company logo

Applied Immune Technologies

tcrl.co.il

Total Raised

$4M

Investors Count

3

Deal Terms

1

Funding, Valuation & Revenue

3 Fundings

Applied Immune Technologies has raised $4M over 3 rounds.

Applied Immune Technologies's latest funding round was a Acquired for on January 27, 2016.

Applied Immune Technologies's valuation in April 2010 was $21.5M.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

1/27/2016

Acquired

$XXM

0

FY undefined

1

4/26/2010

Series A

$XXM

$21.5M

0

FY undefined

10

Other Investors

$XXM

0

FY undefined

0

Date

1/27/2016

4/26/2010

Round

Acquired

Series A

Other Investors

Amount

$XXM

Investors

Valuation

$XXM

$21.5M

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

0

Start free trial
New call-to-action

Applied Immune Technologies Deal Terms

1 Deal Term

Applied Immune Technologies's deal structure is available for 1 funding round, including their Series A from April 26, 2010.

Round

Series A

Funding Date

$XXM

Pre-Money Valuation

$XXM

Post-Money Valuation

$XXM

Amount Raised

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

Board Voting

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Applied Immune Technologies Investors

3 Investors

Applied Immune Technologies has 3 investors. Adicet Bio invested in Applied Immune Technologies's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

1/27/2016

1/27/2016

1
Acquired

Corporation

California

00/00/0000

00/00/0000

Pontifax

Subscribe to see more

Venture Capital

Israel

OrbiMed

Subscribe to see more

Venture Capital

New York

First funding

1/27/2016

00/00/0000

Last Funding

1/27/2016

00/00/0000

Investor

Pontifax

OrbiMed

Rounds

1
Acquired

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Venture Capital

Venture Capital

Location

California

Israel

New York

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.